• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾结石中结石成分与尿液过饱和度的相关性

Correspondence between stone composition and urine supersaturation in nephrolithiasis.

作者信息

Parks J H, Coward M, Coe F L

机构信息

Department of Medicine, University of Chicago, Illinois, USA.

出版信息

Kidney Int. 1997 Mar;51(3):894-900. doi: 10.1038/ki.1997.126.

DOI:10.1038/ki.1997.126
PMID:9067927
Abstract

Supersaturation (SS) with respect to calcium oxalate monohydrate (COM), brushite (Br) and uric acid (UA), obtained in three 24-hour pretreatment urine samples from patients with stone disease were compared to the mineral composition of stones passed by the same patients to determine whether sparse urine SS measurements accurately reflect the long-term average SS values in the kidney and final urine. Among males and females elevation of SS above same sex normals corresponded to composition. As well, treatments that reduced stone rates also reduced these SS values. The degree of calcium phosphate (CaP) admixture was accurately matched by shifting magnitudes of COM and Br SS. As well, increasing CaP content was associated with falling urine citrate and rising urine pH, suggesting renal tubular acidosis. We conclude that sparse urine SS measurements accurately track stone admixtures, and are a reliable index of average renal and urine SS.

摘要

将结石病患者的三份24小时预处理尿液样本中获得的相对于一水草酸钙(COM)、透钙磷石(Br)和尿酸(UA)的过饱和度(SS),与同一患者排出的结石矿物质成分进行比较,以确定少量尿液SS测量值是否能准确反映肾脏和最终尿液中的长期平均SS值。在男性和女性中,SS高于同性正常水平与结石成分相对应。此外,降低结石发生率的治疗方法也降低了这些SS值。COM和Br SS的变化幅度准确匹配了磷酸钙(CaP)的混合程度。此外,CaP含量增加与尿枸橼酸盐降低和尿pH值升高相关,提示肾小管酸中毒。我们得出结论,少量尿液SS测量值能准确追踪结石混合物,是肾脏和尿液平均SS的可靠指标。

相似文献

1
Correspondence between stone composition and urine supersaturation in nephrolithiasis.肾结石中结石成分与尿液过饱和度的相关性
Kidney Int. 1997 Mar;51(3):894-900. doi: 10.1038/ki.1997.126.
2
Dependence of upper limit of metastability on supersaturation in nephrolithiasis.肾结石中过饱和度对亚稳上限的依赖性。
Kidney Int. 1997 Dec;52(6):1602-8. doi: 10.1038/ki.1997.491.
3
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.枸橼酸钾对高钙尿症模型中磷酸钙结石的影响。
J Am Soc Nephrol. 2015 Dec;26(12):3001-8. doi: 10.1681/ASN.2014121223. Epub 2015 Apr 8.
4
Evaluation of factors involved in calcium stone formation.钙结石形成相关因素的评估。
Miner Electrolyte Metab. 1987;13(3):201-8.
5
Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.肾结石中草酸钙二水合物的代谢性尿液相关因素。
J Urol. 1998 Mar;159(3):664-8.
6
Supersaturation and stone composition in a network of dispersed treatment sites.分散治疗点网络中的过饱和与结石成分
J Urol. 1998 Jun;159(6):1821-5. doi: 10.1016/S0022-5347(01)63164-1.
7
Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.远端小管中磷酸钙和草酸钙的过饱和度估计水平。
Urol Res. 1997;25(2):153-9. doi: 10.1007/BF01037933.
8
Divergence between stone composition and urine supersaturation: clinical and laboratory implications.结石成分与尿液过饱和度之间的差异:临床及实验室意义
J Urol. 1999 Apr;161(4):1077-81.
9
[Correlations between crystalluria and composition of calculi].[晶体尿与结石成分之间的相关性]
Prog Urol. 1999 Sep;9(4):633-41.
10
Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.随时间推移结石磷酸盐含量增加和未增加的肾钙结石患者的尿液pH值。
Nephrol Dial Transplant. 2009 Jan;24(1):130-6. doi: 10.1093/ndt/gfn420. Epub 2008 Jul 28.

引用本文的文献

1
Kidney stone disease: risk factors, pathophysiology and management.肾结石疾病:危险因素、病理生理学及管理
Nat Rev Nephrol. 2025 Aug 11. doi: 10.1038/s41581-025-00990-x.
2
Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR).吲达帕胺或氯噻酮降低尿过饱和度用于肾结石二级预防:一项随机、双盲、交叉试验(INDAPACHLOR)的方案
BMJ Open. 2025 Jun 16;15(6):e101594. doi: 10.1136/bmjopen-2025-101594.
3
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial.
恩格列净用于患有钙和尿酸肾结石的非糖尿病个体:一项随机2期试验。
Nat Med. 2025 Jan;31(1):286-293. doi: 10.1038/s41591-024-03330-x. Epub 2025 Jan 2.
4
The Conundrum of Alkali Therapy in Calcium Phosphate Stone Formers.磷酸钙结石患者的碱疗法难题
Kidney Int Rep. 2023 Dec 26;9(3):721-724. doi: 10.1016/j.ekir.2023.12.020. eCollection 2024 Mar.
5
Urinary supersaturation in a Randomized trial among Individuals with Nephrolithiasis comparing Empiric versus selective therapy (URINE): design and rationale of a clinical trial.随机试验中肾结石患者经验性与选择性治疗的尿饱和度比较(URINE):临床试验的设计和原理。
Urolithiasis. 2023 Jan 4;51(1):28. doi: 10.1007/s00240-022-01400-8.
6
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.国际尿石症联盟(IAU)尿路结石代谢评估与医学管理指南。
Urolithiasis. 2022 Dec 1;51(1):4. doi: 10.1007/s00240-022-01387-2.
7
Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.准确测定应用半胱氨酸结合巯基药物患者的 24 小时尿液胱氨酸定量。
Urolithiasis. 2022 Dec;50(6):721-727. doi: 10.1007/s00240-022-01364-9. Epub 2022 Oct 6.
8
Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1.AIM/CD5L 和 KIM-1 实现两种独立的肾结石抑制模式。
Commun Biol. 2022 Aug 3;5(1):783. doi: 10.1038/s42003-022-03750-w.
9
renal stem cells enhance fitness by delayed remodeling of adult Malpighian tubules.肾干细胞通过延迟成年马尔皮基氏小管的重塑来增强适应性。
Sci Adv. 2022 May 20;8(20):eabn7436. doi: 10.1126/sciadv.abn7436.
10
Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial.柠檬酸钙与碳酸钙在慢性甲状旁腺功能减退症治疗中的比较:一项随机、双盲、交叉临床试验。
J Bone Miner Res. 2022 Jul;37(7):1251-1259. doi: 10.1002/jbmr.4564. Epub 2022 Jun 24.